Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Rheumatology
>
EULAR 2019
EULAR 2019
European Congress of Rheumatology
12–15 June 2019
Madrid, Spain
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Letter from the Editor
Editor
Prof. Dennis McGonagle, University of Leeds, United Kingdom
Efficacy and safety of ixekizumab versus adalimumab in patients with PsA
Presented By
Dr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA
Rheumatoid Arthritis
Cohort study shows improvement during 25 years of RA treatment
Presented By
Dr Xanthe Matthijssen, Leiden University Medical Center, the Netherlands
Filgotinib in RA patients with inadequate response or naïve to methotrexate
Presented By
Prof. Rene Westhovens, University Hospital Leuven, Belgium
Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure
Presented By
Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA
Peficitinib likely efficacious and safe
Short methotrexate stop is safe in patients with RA
Presented By
Dr Min Jung Kim, Seoul National University Hospital, South Korea
Tofacitinib is safe according to real-world data analysis
Presented By
Dr Joel Kremer, Albany Medical College, New York, USA
Switching upadacitinib and adalimumab is beneficial in refractory RA
Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab
Presented By
Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany
Efficacy and safety of E6011 in RA patients with inadequate response to methotrexate
Presented By
Dr Yoshiya Tanaka, University of Occupational and Environmental Health, Japan
Preliminary efficacy and safety data of RG6125 in RA patients with an inadequate response to TNF inhibitors
Presented By
Uwe Junker, Roche Innovation Center Basel, Switzerland
Integrated 10-year analysis confirms safety profile abatacept
Presented By
Dr Teresa Simon, Bristol-Myers Squibb, USA
Switching among multiple infliximab biosimilars does not cause immunogenicity
Presented By
Dr Jéróme Avouac, Paris Descartes University, France
Switch to sarilumab from adalimumab is efficacious and safe
Presented By
Dr Gerd Burmester, Free University and Humboldt University of Berlin, Germany
Axial Spondyloarthritis
Treat-to-target approach emerging in axial spondyloarthritis
Presented By
Dr Pedro Machado, University College London Hospitals, United Kingdom
NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors
Presented By
Dr Olafur Palsson, University Hospital Reykjavik, Iceland
Psoriatic Arthritis
Efficacy and safety of ixekizumab versus adalimumab in patients with PsA
Presented By
Dr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA
Efficacy and safety of bimekizumab in patients with active PsA
Presented By
Dr Christopher Ritchlin, University of Rochester Medical Centre, USA
Filgotinib is efficacious and safe in PsA
Presented By
Prof. Philip Mease, Swedish Medical Center and University of Washington, Seattle, USA
Ixekizumab improves signs and symptoms in TNFi-naïve PsA patients
Presented By
Dr Amanda Gellett, Eli Lilly, USA
Etanercept and methotrexate as first-line treatment in PsA
Presented By
Prof. Philip Mease, University of Washington, USA
Unacceptable pain is common in patients with psoriatic arthritis
Presented By
Dr Tor Olofsson, Lund University, Sweden
Osteoarthritis and Osteoporosis
What is new in osteoarthritis
Presented By
Prof. Francis Berenbaum, Sorbonne Université, France
How to treat osteoporosis
Presented By
Prof. Serge Ferrari, Geneva University Hospital, Switzerland
Miscellaneous
Interstitial lung disease in rheumatic diseases and systemic sclerosis
Presented By
Dr Jan Grutters, University Medical Center Utrecht, the Netherlands
Emapalumab in patients with macrophage activation syndrome
Presented By
Dr Fabrizio De Benedetti, Ospedale Pediatrico Bambino Gesù, Italy
Support for tocilizumab use in giant cell arteritis
Presented By
Dr John Stone, Massachusetts General Hospital, Boston, USA